Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N12e provides amino acid supplementation for metabolic and nutritional support pathways.

• Protein‑energy malnutrition: helps restore nitrogen balance and supports tissue repair.
• Post‑operative recovery: contributes to wound healing and lean‑body‑mass preservation.
• Critical illness or severe trauma: assists in maintaining muscle mass and immune function during catabolic stress.

• The amino acid blend supplies substrates for protein synthesis, stimulates the mTOR signaling pathway and provides nitrogen for gluconeogenesis, thereby supporting cellular growth, tissue repair and metabolic homeostasis in patients with increased catabolic demand.

Amino acid solutions may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects

• Nausea: mild gastrointestinal discomfort reported during infusion.
• Vomiting: occasional emesis following administration.
• Headache: transient headache during or after infusion.
• Hyperglycaemia: elevation of blood glucose in susceptible individuals.
• Mild electrolyte shift: slight changes in serum potassium or sodium.
• Local irritation: redness or warmth at the infusion site.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical intervention.
• Sepsis: contamination‑related infection if aseptic technique is breached.
• Metabolic acidosis: significant acid‑base imbalance in vulnerable patients.
• Hyperosmolarity: high osmolar load causing fluid shifts.
• Thrombophlebitis: inflammation of the vein with clot formation.
• Renal impairment: worsening kidney function in patients with pre‑existing disease.

When using Olimel N12e, clinicians should assess patient suitability and monitor relevant parameters.

• Renal function: evaluate creatinine clearance before initiation.
• Hepatic function: check liver enzymes in patients with liver disease.
• Blood glucose: monitor glucose levels in diabetics or hyperglycaemic risk.
• Electrolytes: assess serum electrolytes prior to and during therapy.
• Infusion rate: administer according to recommended speed to reduce irritation.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid solutions can interact with other intravenous therapies and metabolic modifiers.

Major Interactions (Avoid)

• High‑dose insulin: may precipitate severe hypoglycaemia when combined with amino‑acid‑rich solutions.
• Potassium‑rich fluids: risk of hyperkalemia if administered concurrently.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate electrolyte shifts.
• Corticosteroids: can increase protein catabolism, altering the intended benefit.
• Parenteral nutrition admixtures: require compatibility testing to prevent precipitation.
• Anticoagulants: monitor coagulation parameters as amino acids may affect platelet function.